Table 3.

Transfusion characteristics of the patients

Median (IQR)Mean (SD)P
Overall (n = 135) 
Transfusion volume before combination therapy 950 (0-2100) 1106.4 (1041.8) <.001 
Transfusion volume after combination therapy 0 (0-300) 315.6 (616.7)  
Good responder (n = 89) 
Transfusion volume before combination therapy 900 (55-1750) 991.6 (897.9) <.001 
Transfusion volume after combination therapy 0 (0-0) 168.9 (484.7)  
Responders (n = 16) 
Transfusion volume before combination therapy 1575 (555-2362) 1677.5 (1394.2) .003 
Transfusion volume after combination therapy 350 (0-975) 618.7 (748.9)  
Nonresponders (n = 30) 
Transfusion volume before combination therapy 1050 (0-2100) 1142.3 (1158.1) .002 
Transfusion volume after combination therapy 0 (0-1400) 589 (748.5)  
Median (IQR)Mean (SD)P
Overall (n = 135) 
Transfusion volume before combination therapy 950 (0-2100) 1106.4 (1041.8) <.001 
Transfusion volume after combination therapy 0 (0-300) 315.6 (616.7)  
Good responder (n = 89) 
Transfusion volume before combination therapy 900 (55-1750) 991.6 (897.9) <.001 
Transfusion volume after combination therapy 0 (0-0) 168.9 (484.7)  
Responders (n = 16) 
Transfusion volume before combination therapy 1575 (555-2362) 1677.5 (1394.2) .003 
Transfusion volume after combination therapy 350 (0-975) 618.7 (748.9)  
Nonresponders (n = 30) 
Transfusion volume before combination therapy 1050 (0-2100) 1142.3 (1158.1) .002 
Transfusion volume after combination therapy 0 (0-1400) 589 (748.5)  

∼35 of 135 (ie, 25.9% of the patients) were already off transfusion of hydroxyurea only. ∼97 of 135 (ie, 71.9% of the patients) were off transfusion after 6 mo of combination therapy.

IQR, interquartile range.

Close Modal

or Create an Account

Close Modal
Close Modal